Genmab and seagen present first data on tisotumab vedotin (tivdak®) in patients with head and neck squamous cell carcinoma

Media release copenhagen, denmark, and bothell, wash., february 24, 2022
SGEN Ratings Summary
SGEN Quant Ranking